EZH2 depletion potentiates MYC degradation inhibiting neuroblastoma and small cell carcinoma tumor formation
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EZH2 depletion potentiates MYC degradation inhibiting neuroblastoma and small cell carcinoma tumor formation
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-01-10
DOI
10.1038/s41467-021-27609-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Target gene-independent functions of MYC oncoproteins
- (2020) Apoorva Baluapuri et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Tazemetostat: First Approval
- (2020) Sheridan M. Hoy DRUGS
- Targeting PRC2 for the treatment of cancer: an updated patent review (2016 - 2020)
- (2020) Milly Dockerill et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Automethylation of PRC2 promotes H3K27 methylation and is impaired in H3K27M pediatric glioma
- (2019) Chul-Hwan Lee et al. GENES & DEVELOPMENT
- Discovery of a first-in-class EZH2 selective degrader
- (2019) Anqi Ma et al. Nature Chemical Biology
- Proteomic profiling of VCP substrates links VCP to K6‐linked ubiquitylation and c‐Myc function
- (2018) Jan B Heidelberger et al. EMBO REPORTS
- MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis
- (2018) Manpreet Kalkat et al. MOLECULAR CELL
- CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2
- (2017) Liying Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Association with Aurora-A Controls N-MYC-Dependent Promoter Escape and Pause Release of RNA Polymerase II during the Cell Cycle
- (2017) Gabriele Büchel et al. Cell Reports
- N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer
- (2016) Etienne Dardenne et al. CANCER CELL
- Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival
- (2016) Daibiao Xiao et al. MOLECULAR CELL
- Targeting EZH2 in cancer
- (2016) Kimberly H Kim et al. NATURE MEDICINE
- Structural basis of N-Myc binding by Aurora-A and its destabilization by kinase inhibitors
- (2016) Mark W. Richards et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 554 Dual EZH2 and EHMT2 histone methyltransferase inhibition increases biological efficacy in breast cancer cells
- (2014) R. Brown et al. EUROPEAN JOURNAL OF CANCER
- A New Tumorsphere Culture Condition Restores Potentials of Self-Renewal and Metastasis of Primary Neuroblastoma in a Mouse Neuroblastoma Model
- (2014) Dongliang Cao et al. PLoS One
- Quantitative ChIP-Seq Normalization Reveals Global Modulation of the Epigenome
- (2014) David A. Orlando et al. Cell Reports
- Physical Interaction between MYCN Oncogene and Polycomb Repressive Complex 2 (PRC2) in Neuroblastoma
- (2013) Daisy Corvetta et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2
- (2013) S. K. Knutson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MYC on the Path to Cancer
- (2012) Chi V. Dang CELL
- PRC2 directly methylates GATA4 and represses its transcriptional activity
- (2012) A. He et al. GENES & DEVELOPMENT
- EZH2 Generates a Methyl Degron that Is Recognized by the DCAF1/DDB1/CUL4 E3 Ubiquitin Ligase Complex
- (2012) Ji Min Lee et al. MOLECULAR CELL
- EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
- (2012) Michael T. McCabe et al. NATURE
- A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells
- (2012) Sarah K Knutson et al. Nature Chemical Biology
- The Neuronal Differentiation Factor NeuroD1 Downregulates the Neuronal Repellent Factor Slit2 Expression and Promotes Cell Motility and Tumor Formation of Neuroblastoma
- (2011) P. Huang et al. CANCER RESEARCH
- H3K36 Methylation Antagonizes PRC2-mediated H3K27 Methylation
- (2011) Wen Yuan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Context-Specific Regulation of NF-κB Target Gene Expression by EZH2 in Breast Cancers
- (2011) Shuet Theng Lee et al. MOLECULAR CELL
- The Polycomb complex PRC2 and its mark in life
- (2011) Raphaël Margueron et al. NATURE
- Recent Advances in Neuroblastoma
- (2010) John M. Maris NEW ENGLAND JOURNAL OF MEDICINE
- Stabilization of N-Myc Is a Critical Function of Aurora A in Human Neuroblastoma
- (2009) Tobias Otto et al. CANCER CELL
- A Simple PCR Method for Rapid Genotype Analysis of the TH-MYCN Transgenic Mouse
- (2009) Seiki Haraguchi et al. PLoS One
- EZH1 Mediates Methylation on Histone H3 Lysine 27 and Complements EZH2 in Maintaining Stem Cell Identity and Executing Pluripotency
- (2008) Xiaohua Shen et al. MOLECULAR CELL
- Modelling Myc inhibition as a cancer therapy
- (2008) Laura Soucek et al. NATURE
- The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein
- (2008) Xudong Zhao et al. NATURE CELL BIOLOGY
- Genetically-Directed, Cell Type-Specific Sparse Labeling for the Analysis of Neuronal Morphology
- (2008) Thomas Rotolo et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More